Next Article in Journal
Surgical Outcomes of Secondary Alveolar Bone Grafting and Extensive Gingivoperiosteoplasty Performed at Mixed Dentition Stage in Unilateral Complete Cleft Lip and Palate
Next Article in Special Issue
Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19)
Previous Article in Journal
Preeclampsia: The Interplay between Oxygen-Sensitive miRNAs and Erythropoietin
Previous Article in Special Issue
Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
Review

Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China

Department of Pathogen Biology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(2), 575; https://doi.org/10.3390/jcm9020575
Received: 30 January 2020 / Revised: 13 February 2020 / Accepted: 14 February 2020 / Published: 20 February 2020
In December 2019, cases of unidentified pneumonia with a history of exposure in the Huanan Seafood Market were reported in Wuhan, Hubei Province. A novel coronavirus, SARS-CoV-2, was identified to be accountable for this disease. Human-to-human transmission is confirmed, and this disease (named COVID-19 by World Health Organization (WHO)) spread rapidly around the country and the world. As of 18 February 2020, the number of confirmed cases had reached 75,199 with 2009 fatalities. The COVID-19 resulted in a much lower case-fatality rate (about 2.67%) among the confirmed cases, compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Among the symptom composition of the 45 fatality cases collected from the released official reports, the top four are fever, cough, short of breath, and chest tightness/pain. The major comorbidities of the fatality cases include hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis. The source of the virus and the pathogenesis of this disease are still unconfirmed. No specific therapeutic drug has been found. The Chinese Government has initiated a level-1 public health response to prevent the spread of the disease. Meanwhile, it is also crucial to speed up the development of vaccines and drugs for treatment, which will enable us to defeat COVID-19 as soon as possible. View Full-Text
Keywords: coronavirus; pneumonia; 2019-nCoV; clinical characteristics; diagnosis; prevention and control; treatment; public health; COVID-19; SARS-CoV-2 coronavirus; pneumonia; 2019-nCoV; clinical characteristics; diagnosis; prevention and control; treatment; public health; COVID-19; SARS-CoV-2
Show Figures

Figure 1

MDPI and ACS Style

Deng, S.-Q.; Peng, H.-J. Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. J. Clin. Med. 2020, 9, 575. https://doi.org/10.3390/jcm9020575

AMA Style

Deng S-Q, Peng H-J. Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. Journal of Clinical Medicine. 2020; 9(2):575. https://doi.org/10.3390/jcm9020575

Chicago/Turabian Style

Deng, Sheng-Qun; Peng, Hong-Juan. 2020. "Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China" J. Clin. Med. 9, no. 2: 575. https://doi.org/10.3390/jcm9020575

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop